Michel Vounatsos - Net Worth and Insider Trading

Michel Vounatsos Net Worth

The estimated net worth of Michel Vounatsos is at least $6 Million dollars as of 2024-11-13. Michel Vounatsos is the CEO of Biogen Inc and owns about 34,810 shares of Biogen Inc (BIIB) stock worth over $6 Million. Details can be seen in Michel Vounatsos's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michel Vounatsos has not made any transactions after 2020-11-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Michel Vounatsos

To

Michel Vounatsos Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michel Vounatsos owns 3 companies in total, including Revvity Inc (RVTY) , Biogen Inc (BIIB) , and Zai Lab Ltd (ZLAB) .

Click here to see the complete history of Michel Vounatsos’s form 4 insider trades.

Insider Ownership Summary of Michel Vounatsos

Ticker Comapny Transaction Date Type of Owner
RVTY Revvity Inc 2020-03-01 director
BIIB Biogen Inc 2020-11-30 EVP & Chief Commercial Officer
ZLAB Zai Lab Ltd 2023-01-07 director

Michel Vounatsos Latest Holdings Summary

Michel Vounatsos currently owns a total of 1 stock. Michel Vounatsos owns 34,810 shares of Biogen Inc (BIIB) as of November 30, 2020, with a value of $6 Million.

Latest Holdings of Michel Vounatsos

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BIIB Biogen Inc 2020-11-30 34,810 168.28 5,857,827

Holding Weightings of Michel Vounatsos


Michel Vounatsos Form 4 Trading Tracker

According to the SEC Form 4 filings, Michel Vounatsos has made a total of 1 transactions in Biogen Inc (BIIB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Biogen Inc is the acquisition of 3,100 shares on November 30, 2020, which cost Michel Vounatsos around $748,061.

Insider Trading History of Michel Vounatsos

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Michel Vounatsos Trading Performance

GuruFocus tracks the stock performance after each of Michel Vounatsos's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michel Vounatsos is -0.44%. GuruFocus also compares Michel Vounatsos's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michel Vounatsos within 3 months outperforms 3 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Michel Vounatsos's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Michel Vounatsos

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -0.57 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -1.46 LIMIT LIMIT LIMIT LIMIT LIMIT

Michel Vounatsos Ownership Network

Ownership Network List of Michel Vounatsos

No Data

Ownership Network Relation of Michel Vounatsos

Insider Network Chart

Michel Vounatsos Owned Company Details

What does Revvity Inc do?

Who are the key executives at Revvity Inc?

Michel Vounatsos is the director of Revvity Inc. Other key executives at Revvity Inc include Please See Remarks Tajinder Vohra , See Remarks Joel S Goldberg , and Please See Remarks Prahlad R. Singh .

Revvity Inc (RVTY) Insider Trades Summary

Over the past 18 months, Michel Vounatsos made no insider transaction in Revvity Inc (RVTY). Other recent insider transactions involving Revvity Inc (RVTY) include a net sale of 23,810 shares made by Joel S Goldberg , a net sale of 14,379 shares made by Tajinder Vohra , and a net sale of 22,361 shares made by Prahlad R. Singh .

In summary, during the past 3 months, insiders sold 7,311 shares of Revvity Inc (RVTY) in total and bought 0 shares, with a net sale of 7,311 shares. During the past 18 months, 61,400 shares of Revvity Inc (RVTY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 61,400 shares.

Revvity Inc (RVTY)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Revvity Inc Insider Transactions

No Available Data

Michel Vounatsos Mailing Address

Above is the net worth, insider trading, and ownership report for Michel Vounatsos. You might contact Michel Vounatsos via mailing address: Biogen Inc., 225 Binney St., Cambridge Ma 02142.